Bank Julius Baer & Co
GSK icon

Bank Julius Baer & Co’s GSK GSK Stock Holding History

Bank Julius Baer & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-280
Closed -$10.8K – 684
2025
Q2 		$10.8K Hold
280
– – ﹤0.01% 585
2025
Q1 		$10.8K Sell
280
-804
-74% -$29.4K ﹤0.01% 584
2024
Q4 		$40.5K Buy
+1,084
New +$39K ﹤0.01% 573

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank Julius Baer & Co's GSK Position: Q3 2025 in Review

Bank Julius Baer & Co sold out of GSK (GSK) in Q3 2025, closing a stake of 280 shares — an estimated $10.8K sold.

Bank Julius Baer & Co first reported a position in GSK in Q4 2024 and held it in 3 quarters. The position peaked at $40.5K in Q4 2024. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Bank Julius Baer & Co reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Bank Julius Baer & Co sold 280 GSK shares in Q3 2025, an estimated $10.8K.
  • Bank Julius Baer & Co first reported a position in GSK in Q4 2024 and held it in 3 quarters.
  • Bank Julius Baer & Co's GSK position peaked at $40.5K in Q4 2024.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Bank Julius Baer & Co's 13F filing for Q3 2025, filed 13 Nov 2025.